Showing results (751-760 of 911) with videos related to

Sort By:
Pageof 92
Physiological Genomics|February 13, 2001
Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2N S Delany, M Hurle, P Facer, et al.
Plos One|February 24, 2023
Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 studyGeetha Beauchamp, Sybil Hosek, Deborah J Donnell, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Cascades of diabetes and hypertension care in Samoa: Identifying gaps in the diagnosis, treatment, and control continuum - a cross-sectional studyLauren C LaMonica, Stephen T McGarvey, Anna C Rivara, et al.
Infection and Immunity|December 12, 2012
Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccineLuca Fagnocchi, Alessia Biolchi, Francesca Ferlicca, et al.
Nature Medicine|October 5, 2023
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherenceMia Moore, Sarah Stansfield, Deborah J Donnell, et al.
Scientific Reports|September 22, 2017
A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan AfricaVicky Jespers, Jordan Kyongo, Sarah Joseph, et al.
AIDS (London, England)|October 19, 2016
Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapyHelen A Kelly, Bernard Sawadogo, Admire Chikandiwa, et al.
Plos Medicine|November 24, 2011
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling studyTimothy B Hallett, Jared M Baeten, Renee Heffron, et al.
AIDS (London, England)|May 17, 2022
Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African womenDanielle Giovenco, Audrey Pettifor, Kimberly A Powers, et al.
NPJ Vaccines|April 12, 2023
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humansViola Viviani, Adele Fantoni, Sara Tomei, et al.
Pageof 92